Betahistine is NOT contraindicated in coronary artery disease (CAD)
Betahistine can be safely used in patients with coronary artery disease, as CAD is not listed among the contraindications for this medication. The available evidence does not identify cardiac disease as a reason to avoid betahistine.
Contraindications and Precautions
According to the FDA drug label, betahistine (histamine analogue) is contraindicated in:
- Hypotension
- Severe hypertension
- Severe cardiac disease (not routine CAD)
- Severe pulmonary disease
- Severe renal disease
- Pheochromocytoma 1
The 2020 American Academy of Otolaryngology clinical practice guideline for Ménière's disease specifies that betahistine should be avoided only in patients with pheochromocytoma and used with caution in patients with asthma and history of peptic ulcer disease 2. Notably, coronary artery disease is not mentioned as a contraindication or precautionary condition.
Safety Profile
The safety data from over 35 years of postmarketing surveillance covering >130 million patients exposed to betahistine demonstrates a favorable safety profile 3. The most common adverse effects are:
- Cutaneous hypersensitivity reactions (rash, pruritus, urticaria) - typically mild and self-limiting
- Gastrointestinal complaints (nausea, vomiting, abdominal pain)
- Headache, balance disorder, nasopharyngitis
- Palpitations (reported but rare) 2, 3
Serious cardiovascular adverse events are notably absent from the extensive safety surveillance data 3.
Clinical Caveat
The term "severe cardiac disease" in the contraindications 1 likely refers to conditions such as:
- Decompensated heart failure
- Severe valvular disease
- Unstable angina or recent myocardial infarction
- Severe arrhythmias
Stable coronary artery disease does not fall into this category. However, if a patient has both CAD and one of the above severe cardiac conditions, clinical judgment should be exercised, though the contraindication relates to the severity of cardiac dysfunction rather than the presence of atherosclerotic disease itself.
In patients with stable CAD requiring betahistine for vestibular disorders, the medication can be prescribed without specific cardiac contraindication concerns.